• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy

byDaniel GoldshteinandSze Wah Samuel Chan
March 17, 2025
in Chronic Disease, Oncology
Reading Time: 3 mins read
Pain management collage: a calm man resting on a pillow in a hospital gown beside a frosty cold pack and a glowing teal nerve
Share on FacebookShare on TwitterShare on LinkedIn

1. Cooling was found to have a relative risk reduction of 42% and compression had a relative risk reduction of 37%.

2. Quality of life has a minor improvement with cooling and compression interventions.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and often debilitating side effect of cytotoxic drugs, with no established prevention or treatment strategies. There have been limited trials studying cryotherapy and compression with conflicting results. This trial investigated and compared the effectiveness of hand cooling or compression in preventing CIPN in patients undergoing breast cancer taxane-based chemotherapy. The main endpoint was Common Terminology Criteria for Adverse Events (CTCAE) criteria for CIPN and secondary endpoints included quality of life for patients with CIPN (EORTC QLQ-CIPN20), and overall quality of life (EORTC QLQ-C30). The CTCAE criteria found that in the cooling group, 29% of patients in the intervention arm and 50% of patients in the control arm experienced high-grade CIPN with an effect size of 21.15% (significant, relative risk reduction 42%). In the compression group, 24% in the intervention arm and 38% of patients in the control arm experienced CIPN with an effect size 14.29% (relative risk reduction 37%). No significant differences were found between the interventional groups (effect size −5.47%). With regards to nail toxic effects, it was found that for cooling, the effect size was 17.64% compared to control, and for compression, the effect size 8.16% compared to control. EORTC QLQ-CIPN20 found some differences for sensory symptoms (cooling vs control: effect size 4.90%; compression vs control: effect size 3.20%) and motor symptoms (cooling vs control: effect size 2.98%; compression vs control: effect size 2.02%). CIPN scores via CTCAE one month after last taxane application found an effect size 9.52% (significant) in the cooling group, and an effect size 9.38% (non-significant) in the compression group. EORTC QLQ-C30 scores for patients found higher rates of fatigue, reduced physical functioning, reduced social functioning, constipation, insomnia, worse global health status, more pain, nausea and vomiting, in those with high grade CIPN compared to those without. The strengths of the study included its methodology, and the limitations included the sample size. Overall, this study found some improved outcomes with cooling or compression of limbs to prevent CIPN in those undergoing taxane-based chemotherapy.

Click to read the study in JAMA Oncology

Relevant Reading: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update

RELATED REPORTS

No Content Available

In-Depth [randomized controlled trial]: This self-controlled, single-center trial enrolled patients undergoing weekly taxane-based chemotherapy for primary breast cancer and randomized them (1:1) to cooling (n = 61) or compression (n = 61) of the dominant hand. The non-dominant hand or the feet severed as interindividual control. The CTCAE criteria found that in the cooling group, 29% of patients in the intervention arm and 50% of patients in the control arm experienced high-grade CIPN with an effect size of 21.15% (95%CI, 5.98-35.55,  p=0.002, relative risk reduction 42%). In the compression group, 24% in the intervention arm and 38% of patients in the control arm experienced CIPN with an effect size 14.29% (95%CI, 2.02-27.24, p=0.008, relative risk reduction 37%). No significant differences were found between the interventional groups (effect size −5.47% (95%CI, −34.29 to 23.36). With regards to nail toxic effects, it was found that for cooling, the effect size was 17.64% (95%CI, 4.50-30.87) compared to control, and for compression, the effect size 8.16% (95%CI, −1.85 to 19.60) compared to control. EORTC QLQ-CIPN20 found some differences for sensory symptoms (cooling vs control: effect size 4.90% (95%CI, 2.70-7.11]; compression vs control: effect size 3.20% (95%CI, 0.09-6.31)) and motor symptoms (cooling vs control: effect size 2.98% (95%CI, 0.99-4.97); compression vs control: effect size 2.02% (95%CI, −0.25 to 4.29)). CIPN scores via CTCAE one month after last taxane application found an effect size 9.52% (95%CI, −2.16 to 22.62, p=0.046) in the cooling group, and an effect size 9.38% (95%CI, −4.91 to 25.02, p=0.08) in the compression group. EORTC QLQ-C30 scores for patients found higher rates of fatigue, reduced physical functioning, reduced social functioning, constipation, insomnia, worse global health status, more pain, nausea and vomiting, in those with high grade CIPN compared to those without. Overall, this study found some improved outcomes with cooling or compression of limbs to prevent CIPN in those undergoing taxane-based chemotherapy.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chemotherapy induced neuropathycompressioncyrotherapy
Previous Post

#VisualAbstract: Male-Partner Treatment Effectively Prevents Recurrence of Bacterial Vaginosis

Next Post

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer

RelatedReports

No Content Available
Next Post
Everyday medicines collage: an older woman in round glasses behind plain tablets and capsules on a napkin and a water glass

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer

Pregnancy care collage: a drawing of a head-down fetus in the uterus, a fetal listening horn and knitted baby booties

Safer Births Bundle of Care reduces perinatal mortality in Tanzania

Brain bleed care collage: a smiling older woman in a knit shawl, a forked artery with a small round bulge and a teacup

Liberal transfusion strategy not beneficial in treating aneurysmal subarachnoid hemorrhage

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
  • Gait analysis predicts health, sleep, and medication use across 18 body systems
  • Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.